SLC5A2 and type 2 diabetes mellitus: Diabetic db/db mice, a model of type 2 diabetes, that were fed a HFD and treated with an SGLT2 inhibitor, TA-1887 for 4 months exhibited reduced inflammation, oxidative stress, and cellular senescence, especially in the visceral white adipose tissue60.